Clinical trialNCT04855747TerminatedPhase 3Interventional

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

SponsorLevomecor Inc.Enrollment236DepressionMajor Depressive Disorder

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Paul Greene, PhD
Relmada Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Relmada Site
Homewood, Alabama, United States
Relmada Site
Chandler, Arizona, United States
Relmada Site
Chandler, Arizona, United States
Relmada Site
Phoenix, Arizona, United States
Relmada Site
Tucson, Arizona, United States
Relmada Site
Bryant, Arkansas, United States
Relmada Site
Anaheim, California, United States
Relmada Site
Bellflower, California, United States
Relmada Site
Encino, California, United States
Relmada Site
Lafayette, California, United States
Relmada Site
Los Angeles, California, United States
Relmada Site
Newport Beach, California, United States
Relmada Site
Orange, California, United States
Relmada Site
Redlands, California, United States
Relmada Site
Santa Ana, California, United States
Relmada Site
Stanford, California, United States
Relmada Site
Temecula, California, United States
Relmada Site
Upland, California, United States
Relmada Site
Denver, Colorado, United States
Relmada Site
Brandon, Florida, United States
Relmada Site
Hialeah, Florida, United States
Relmada Site
Jacksonville, Florida, United States
Relmada Site
Maitland, Florida, United States
Relmada Site
Miami, Florida, United States
Relmada Site
Miami, Florida, United States
Relmada Site
Miami, Florida, United States
Relmada Site
Miami, Florida, United States
Relmada Site
Miami, Florida, United States
Relmada Site
Miami Springs, Florida, United States
Relmada Site
Okeechobee, Florida, United States
Relmada Site
Tampa, Florida, United States
Relmada Site
West Palm Beach, Florida, United States
Relmada Site
Savannah, Georgia, United States
Relmada Site
Boise, Idaho, United States
Relmada Site
Chicago, Illinois, United States
Relmada Site
Chicago, Illinois, United States
Relmada Site
Elgin, Illinois, United States
Relmada Site
Overland Park, Kansas, United States
Relmada Site
Marrero, Louisiana, United States
Relmada Site
Baltimore, Maryland, United States

30 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Mar 2021
Primary completion: 31 Dec 2024
Completion: 14 Jan 2025
Last update posted: 10 Jul 2026
Registered enrollment: 236
Registry id: NCT04855747

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.